This test is most useful if any of these apply to you.
Vitamin B6 quietly powers hundreds of reactions in your body, from making brain chemicals to processing protein. The catch: standard blood tests rarely look at it, and even when they do, a single snapshot can miss how fast your body is burning through it.
Urinary 4-PA (4-pyridoxic acid) is the main breakdown product your body excretes after using vitamin B6. Measuring it offers a window into recent B6 intake, how quickly your cells are turning over this vitamin, and how well your kidneys are clearing certain waste products.
Vitamin B6 enters your body from food or supplements, gets converted in the liver into its active form, and then gets used up inside your cells. What's left over is 4-PA, which leaves the body through urine. Because urine is where this molecule exits, a urine measurement reflects how much B6 your body has recently processed.
In healthy adults, 4-PA is the dominant form of vitamin B6 found in urine, with other forms present in much smaller amounts. Research using a controlled feeding study in 19 adults (5 men and 14 women) showed a moderate positive correlation between the 4-PA-to-creatinine ratio from a random urine sample and a full 24-hour collection for tracking B6 status. That makes a single timed urine sample a reasonable, more practical alternative for many situations, though it captures less precision than a full 24-hour collection.
The most informative use of 4-PA isn't the absolute level but a ratio that compares 4-PA to the active form of vitamin B6 in blood. Researchers call this concept B6 turnover. Two related versions exist: the simpler 4-PA-to-PLP ratio (used in several U.S. national-survey studies) and the formal PAr index, which divides 4-PA by the sum of PL (pyridoxal) and PLP (pyridoxal 5'-phosphate). Both ratios capture similar biology and both tend to rise when there is ongoing inflammation in the body, but they are not identical.
Think of it this way: low B6 in your blood could mean you're not eating enough, or it could mean your body is burning through it faster than usual. The turnover ratio helps tell the difference, which has real consequences for what an intervention should look like.
Higher B6 turnover has been linked to a higher risk of dying from any cause. In a study of 15,304 adults from the general U.S. population, faster vitamin B6 breakdown was associated with greater all-cause mortality, with the association reaching statistical significance specifically among adults older than 65. A separate study of 4,881 older adults found that lower blood B6 levels combined with higher turnover rates were linked to greater cardiovascular and overall death risk.
Among 2,574 adults with type 2 diabetes, those with the lowest active B6 and the highest 4-PA had the worst survival. In a separate group of 2,074 people with type 2 diabetes, a higher 4-PA-to-PLP ratio was a strong predictor of long-term death, independent of standard inflammation and kidney markers. These findings are observational, so they show association, not proof of cause.
In the Hordaland Health Study of 6,539 community-dwelling adults, higher PAr (a B6 turnover ratio) predicted greater overall cancer incidence, especially lung cancer. The proposed mechanism is that increased B6 catabolism reflects systemic inflammation, a known driver of cancer risk. PAr added information beyond simple B6 intake.
An analysis of 8,063 adults from a U.S. national survey found that higher blood PLP was linked to lower odds of liver scarring, while a higher 4-PA-to-PLP ratio was linked to higher odds of scarring. The pattern held across age and health subgroups, suggesting B6 turnover tracks something real about underlying liver inflammation.
More than 80% of 4-PA's removal by the kidneys flows through specific transporters in the OAT family, with OAT3 playing the dominant role and OAT1 also contributing. This makes urinary 4-PA an unusually clean readout of how well that transporter system is working. In a large kidney disease cohort, people whose kidneys cleared less 4-PA had a higher risk of disease progression, independent of standard markers like eGFR and urine protein.
What this means for you: if your urinary 4-PA looks off in the context of normal eGFR, it may reflect early changes in kidney tubular function that routine tests can miss. It also has implications for how your kidneys handle certain medications.
In a study of 172 adults with type 2 diabetes compared to people without diabetes, those with diabetes had lower active B6 in blood but a higher proportion of 4-PA among total urinary B6 forms. The pattern is consistent with faster B6 breakdown in diabetes, particularly when early kidney involvement is present, though the cross-sectional design cannot prove that diabetes itself drives the shift. Sex differences also emerged, with women showing higher urinary 4-PA excretion than men.
Urinary 4-PA reflects recent vitamin B6 intake, typically over the past 1 to 2 weeks. That makes a single reading sensitive to what you ate this week, whether you took a multivitamin, and short-term hormonal shifts. In a small study of 34 healthy women, 4-PA showed menstrual-cycle rhythmicity, with lower values around ovulation tied to hormonal changes in B6 turnover. The evidence base for this cycle effect is thin and based on a single cohort.
Build a trend instead of trusting a single snapshot. Get a baseline reading. If you change something meaningful, such as starting a B-complex supplement, modifying your diet, or addressing a chronic inflammatory condition, retest in 3 to 6 months. Then check at least annually to confirm your levels and turnover ratio are stable. Pair urinary 4-PA with a blood PLP measurement so you can calculate the turnover ratio, which is more informative than either value alone.
Several factors can distort a single reading. Knowing them helps you avoid drawing the wrong conclusion:
If your urinary 4-PA is unexpectedly low, your first questions should be about intake. Are you eating B6-containing foods regularly? Are you on an oral contraceptive or other medication that influences B6 metabolism? Pair the result with a blood PLP test to determine whether active B6 in your bloodstream is also low, which would point toward true deficiency rather than just low recent intake.
If your turnover ratio (4-PA divided by PLP) is unexpectedly high, look for sources of inflammation. Order high-sensitivity CRP (hs-CRP, a blood marker of inflammation) and a comprehensive metabolic panel, and consider whether a chronic condition such as diabetes, autoimmune disease, or undiagnosed liver issues could be contributing. A nephrologist or metabolic specialist may be useful if kidney clearance appears compromised. If you have type 2 diabetes or kidney disease, the turnover ratio is worth tracking systematically as part of your long-term risk profile.
Most labs accept either a 24-hour urine collection or a random spot urine sample with a creatinine measurement to normalize the result. The spot sample is far more practical and, based on controlled feeding research, gives results that correlate moderately well with a 24-hour collection, though with less precision. Collect when you're following your usual diet, not after an unusual meal or supplement binge, and note any recent B-vitamin supplementation so the lab interpretation is accurate.
Evidence-backed interventions that affect your Pyridoxic Acid level
Pyridoxic Acid is best interpreted alongside these tests.
Pyridoxic Acid is included in these pre-built panels.